The choice between purchasing a nuclear camera or using a mobile service is an important decision for your practice. A broad range of factors shape the decision, and following a “cookie cutter” formula is not recommended. Understanding the unique dynamics at work in your practice can shed light on which
Digirad today announced the launch of updated versions of its Ergo general-purpose nuclear camera, and Cardius line of SPECT cameras. The upgraded cameras were developed throughout 2019 and are making their clinical debut this quarter in markets throughout the United States and Canada. The updates bring consolidated functionality, enhanced battery life, and improved portability
With the continual advancements in healthcare technology and service, investing in your cardiac practice, upgrading equipment, and improving efficiency is an ongoing process. One of the most significant considerations is not only when to replace a camera, but also if refurbished, or new equipment might be a better decision. It’s
Download a PDF version of this infographic
Digirad is proud to introduce the new Cardius X-ACT+ Imaging System. We’ve taken the X-ACT camera and completely redesigned it to offer more patient-centric features and deliver significant benefits while reducing the cost burden to the healthcare system. Technology The X-ACT+ is the only SPECT/FAC MPI system that features a
Digirad has expanded its offerings as a nuclear medicine company by adding a variable angle camera to its growing array of high-quality imaging equipment. Through their relationship with Universal Medical Resources, Inc., the exclusive North America distributor for DDD Diagnostic, Digirad has added the CorCam™ and QuantumCam™ cameras to its
Solid-state cameras from Digirad are smaller, lighter, and more compact than what you typically find with other nuclear gamma cameras. Our Ergo, Cardius® 2XPO, Cardius® 3XPO and Cardius® X-ACT imaging systems are conveniently sized, and can fit into standard-sized exam rooms and door frames without special modifications. So the short
